TickerSpark Feed

VKTX coverage

Every article, report, and earnings note where VKTX appears.

What to Watch as Retension Pharmaceuticals Prices on Nasdaq
IPORTSN

What to Watch as Retension Pharmaceuticals Prices on Nasdaq

Retension Pharmaceuticals Inc. (NASDAQ: RTSN) is expected to list on 2026-10-09, and the company has not disclosed a price range. The IPO is priced, with 3,300,000 shares offered and a disclosed market cap of $41.25 million. The setup is straightforward: shareholders should watch whether RTN-001’s Phase 2b data can support a larger hypertension story, but the stock still carries classic single-asset biotech risk.

Oct 7, 20265 MIN
On-Demand Research

Want a deeper dive on VKTX?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate VKTX Report